MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $39,000 | -61.0% | 31,595 | -2.2% | 0.00% | – |
| Q1 2017 | $100,000 | -45.7% | 32,308 | -3.5% | 0.00% | – |
| Q4 2016 | $184,000 | -15.2% | 33,482 | -1.8% | 0.00% | – |
| Q3 2016 | $217,000 | +197.3% | 34,087 | +154.7% | 0.00% | – |
| Q2 2016 | $73,000 | -13.1% | 13,383 | +32.4% | 0.00% | – |
| Q1 2016 | $84,000 | +5.0% | 10,105 | 0.0% | 0.00% | – |
| Q4 2015 | $80,000 | -4.8% | 10,105 | +2.5% | 0.00% | – |
| Q3 2015 | $84,000 | -11.6% | 9,859 | +28.0% | 0.00% | – |
| Q2 2015 | $95,000 | +3.3% | 7,700 | 0.0% | 0.00% | – |
| Q1 2015 | $92,000 | +5.7% | 7,700 | 0.0% | 0.00% | – |
| Q4 2014 | $87,000 | +27.9% | 7,700 | 0.0% | 0.00% | – |
| Q3 2014 | $68,000 | +15.3% | 7,700 | -5.8% | 0.00% | – |
| Q2 2014 | $59,000 | +103.4% | 8,170 | +40.9% | 0.00% | – |
| Q1 2014 | $29,000 | +61.1% | 5,800 | +65.7% | 0.00% | – |
| Q4 2013 | $18,000 | +38.5% | 3,500 | 0.0% | 0.00% | – |
| Q3 2013 | $13,000 | +85.7% | 3,500 | +250.0% | 0.00% | – |
| Q2 2013 | $7,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,244,080 | $12,096,000 | 4.51% |
| ALTFEST L J & CO INC | 39,491 | $1,653,000 | 1.15% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $446,000 | 0.44% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,074,557 | $48,912,000 | 0.40% |
| Virtus ETF Advisers LLC | 87,477 | $472,000 | 0.35% |
| Cannell & Co. | 1,614,678 | $8,703,000 | 0.32% |
| Birchview Capital, LP | 44,000 | $237,000 | 0.17% |
| STONERIDGE INVESTMENT PARTNERS LLC | 180,534 | $973,000 | 0.14% |
| HighPoint Advisor Group LLC | 8,484 | $344,000 | 0.12% |
| MARINER INVESTMENT GROUP LLC | 63,090 | $340,000 | 0.12% |